CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
78.84
+0.05 (0.06%)
At close: Apr 9, 2026, 4:00 PM EDT
78.76
-0.08 (-0.10%)
After-hours: Apr 9, 2026, 7:59 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 18 analysts that cover CVS Health stock have a consensus rating of "Strong Buy" and an average price target of $94.61, which forecasts a 20.00% increase in the stock price over the next year. The lowest target is $80 and the highest is $102.
Price Target: $94.61 (+20.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 8 | 8 | 7 | 7 |
| Buy | 11 | 11 | 10 | 10 | 11 | 11 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 18 | 19 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $101 → $99 | Buy | Maintains | $101 → $99 | +25.57% | Mar 31, 2026 |
| Bernstein | Bernstein | Hold → Buy Upgrades $91 → $94 | Hold → Buy | Upgrades | $91 → $94 | +19.23% | Mar 12, 2026 |
| Argus Research | Argus Research | Strong Buy Maintains $91 → $90 | Strong Buy | Maintains | $91 → $90 | +14.16% | Jan 28, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $100 → $95 | Strong Buy | Maintains | $100 → $95 | +20.50% | Jan 27, 2026 |
| Bernstein | Bernstein | Hold Maintains $87 → $91 | Hold | Maintains | $87 → $91 | +15.42% | Jan 6, 2026 |
Financial Forecast
Revenue This Year
409.43B
from 399.83B
Increased by 2.40%
Revenue Next Year
427.59B
from 409.43B
Increased by 4.44%
EPS This Year
7.24
from 1.39
Increased by 420.85%
EPS Next Year
8.26
from 7.24
Increased by 14.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 450.4B | 468.4B | |||
| Avg | 409.4B | 427.6B | |||
| Low | 388.2B | 400.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.6% | 14.4% | |||
| Avg | 2.4% | 4.4% | |||
| Low | -2.9% | -2.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.77 | 9.24 | |||
| Avg | 7.24 | 8.26 | |||
| Low | 6.83 | 7.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 459.0% | 27.6% | |||
| Avg | 420.9% | 14.1% | |||
| Low | 391.4% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.